Cell Source, Inc. SEC filings CLCS

Cell Source, Inc. has 139 filings in SEC EDGAR's recent list, going back to Mar 5, 2013. Its latest annual report, Form 10-K, was filed on Apr 7, 2026 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Jun 27, 2025 (auditor change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Apr 7, 2026 Dec 31, 2024
10-K Annual report Jun 24, 2024 Dec 31, 2023
10-K Annual report Aug 8, 2023 Dec 31, 2022
10-K Annual report Apr 15, 2022 Dec 31, 2021
10-K Annual report Apr 15, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K/A Amended annual report Jun 19, 2019 Dec 31, 2018
10-K Annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Jul 25, 2018 Dec 31, 2017
10-K Annual report Apr 14, 2016 Dec 31, 2015
10-K Annual report Mar 13, 2015 Dec 31, 2014
10-K Annual report Mar 25, 2014 Dec 31, 2013

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLCS (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1569340
Former names
TICKET TO SEE, INC. (until Jun 26, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.